BioCryst Pharmaceuticals BCRX State income taxes – net of federal income tax benefit
State income taxes – net of federal income tax benefit at other companies
Other financials
Where this comes from
Reported directly by BioCryst Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes.
The official record: BioCryst Pharmaceuticals’s 10-K, filed February 26, 2026, on SEC EDGAR. View the filing →
Ask your AI about BioCryst Pharmaceuticals's state income taxes – net of federal income tax benefit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is BioCryst Pharmaceuticals's state income taxes – net of federal income tax benefit?
- BioCryst Pharmaceuticals (BCRX) reported state income taxes – net of federal income tax benefit of 1% in Q4 2025.
- What does state income taxes – net of federal income tax benefit mean?
- The net impact of state and local income taxes on the effective tax rate, adjusted for the federal tax deduction benefit. It provides a clearer view of the actual incremental tax cost incurred by the company due to state-level operations.